Status:
COMPLETED
Impact of Vitamin D on Diabetic Kidney Disease in African Americans
Lead Sponsor:
Medical University of South Carolina
Conditions:
Diabetic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This purpose of this project is to evaluate the effectiveness of vitamin D supplementation over 12 months in vitamin D deficient African American adults with type 2 diabetes.
Detailed Description
Diabetic kidney disease is increasing in prevalence and is associated with significant morbidity and mortality. Health disparities exist in the progression of diabetic kidney disease, with minorities ...
Eligibility Criteria
Inclusion
- African American race
- Diagnosis of Type 2 Diabetes
- Stage 1 or 2 Kidney Disease with detectable microalbuminuria \>4.0 (mg/g) 25(OH)D level \<20 ng/ml
Exclusion
- Type 1 diabetes
- -\> Stage 3 Kidney Disease, or history of dialysis, kidney transplantation or nephrolithiasis
- Unable to provide informed consent or contact information
- Pre-existing calcium or parathyroid condition, including serum calcium \>10.2 mg/dL
- Sarcoidosis, active tuberculosis, or malignancy
- Known hypersensitivity to vitamin D or any of its analogues and derivatives
- Current pregnancy or planning to become pregnant in next 15 months
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01214356
Start Date
August 1 2010
End Date
July 1 2013
Last Update
October 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425